We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FGBIP:NASDAQFirst Guaranty Bancshares, Inc. - 6.75% Series A Fixed-Rate Non-Cumulative Perpetual Preferred Stock Analysis

Data as of 2026-10-01 - not real-time

$17.28

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

First Guaranty Bancshares, Inc. is priced at $17.28, and its moving averages give no clean directional read — the structure is neutral. It has lost 9.6% over the past 30 days. Momentum indicators put RSI at 27.5 (oversold) with MACD reading bearish. The recent range runs from support at $17.15 up to resistance at $18.51.
On valuation the read is undervalued — earnings multiple of 6.6 versus a 15.1 sector average, below the peer group. Revenue is growing at 176.8% on a -96.5% profit margin. The 9.79% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 13.1%, a beta of 0.22 and a maximum drawdown of 25.3%, position sizing matters here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
The horizons line up on hold — conviction 1 out of 10.

Top Market Events

HAMMOND, La., July 28, 2026 GLOBE NEWSWIRE -- First Guaranty Bancshares, Inc. "First Guaranty" NASDAQ: FGBI , the...Nasdaq2monFirst Guaranty Bancshares, Inc.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • RSI at 27.5 signals oversold conditions
  • Trading below the 200-day average of 18.41
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • RSI at 27.5 signals oversold conditions
  • P/E of 6.6 versus sector average of 15.1
  • Trading below the 200-day average of 18.41

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 6.6 versus sector average of 15.1
  • Negative profit margin of -96.5%
  • Negative return on equity of -14.8%

Key Metrics & Analysis

Financial Health

Revenue Growth176.80%
Profit Margin-96.50%
P/E Ratio6.6
ROE-14.84%
ROA-0.92%
P/B Ratio1.5
Op. Cash Flow$54.5M
Industry P/E15.1

Technical Analysis

TrendNeutral
RSI27.5
Support$17.15
Resistance$18.51
MA 20$17.79
MA 50$18.75
MA 200$18.41
MACDBearish
VolumeDecreasing
Fear & Greed Index90.88

Valuation

GradeUndervalued
TypeValue
Dividend Yield9.79%

Risk Assessment

Beta0.22
Volatility13.08%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.